Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma

Hannah A. Blair

首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma

【24h】

Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma

机译：纠正：Daratumumab：复发和/或难治性多骨髓瘤的审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The author has alerted us to the following error in Sect. 4.2.2.1, and the following correction should be noted:

机译：作者在Sect中提醒我们以下错误。4.2.2.1，并应注意以下更正：

著录项

来源
《Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts》 |2018年第3期|共1页
作者
Hannah A. Blair;
展开▼
作者单位

Springer;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function [J] . Shao-long HE, Yu-hang CHENG, Di WANG, 当代医学科学(英文) . 2021,第003期
2. Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma [J] . Yun Leng, Wenming Chen, Lugui Qiu, 癌症（英文版） . 2016,第012期
3. Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma： an open-label,observational, multi-center study in China [J] . YUAN Zhen-gang, JIN Jie, HUANG Xiao-jun, 中华医学杂志：英文版 . 2011,第019期
4. Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma [J] . Hannah A. Blair Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2018,第3期

机译：纠正：Daratumumab：复发和/或难治性多骨髓瘤的审查
5. Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma [J] . Hannah A. Blair Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2017,第18期

机译：Daratumumab：复发和/或难治性多发性骨髓瘤的审查
6. Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma ( GEN GEN 503): final results of an open‐label, phase 1/2 study [J] . Plesner Torben, Arkenau Hendrik‐Tobias, Gay Francesca, British Journal of Haematology . 2019,第3期

机译：在复发或复发/难治性多发性骨髓瘤（Gen Gen 503）中的患者中，达拉姆宫和地塞米松组合的疗效和耐受性与Lenalalomide和地塞米松组合的疗效和耐受性：开放标签，第1/2期研究的最终结果
7. Durability of Response with Thalidomide Therapy for Relapsed Multiple Myeloma [C] . B. Myers, S.G. Jones, G. Do I an European Haematology Association . 2002

机译：耐久性耐久性与多发性骨髓瘤复发疗法
8. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
9. Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation [O] . Chen-lu Yang, Neng-gang Jiang, Li Zhang, 2021

机译：复发/难治性多发性骨髓瘤转化的等离子体细胞白血病用达拉穆曼成功处理然后进行自体干细胞移植
10. Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma ( GEN 503): final results of an open‐label, phase 1/2 study [O] . Torben Plesner, Hendrik‐Tobias Arkenau, Francesca Gay, 2019

机译：在复发或复发/难治多骨髓瘤（Gen 503）中的患者中，达拉姆姆人和地塞米德和地塞米松组合的疗效和耐受性：开放标签，第1/2期研究的最终结果
11. Health Technology Review No. 12, August 1995. Hematopoietic Stem-CellTransplantation in Multiple Myeloma [R] . Handelsman, H. 1995

机译：卫生技术评论第12期，1995年8月。多发性骨髓瘤的造血干细胞移植

Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma

摘要

著录项

相似文献

相关主题

期刊订阅